SULPIRIDE,(+)
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
- Ligand Name - Name of the test ligand
Test Ligand ID | 1781 |
---|---|
Ligand Name | SULPIRIDE,(+) |
PubMed Compound Id | 5355 |
Structure | |
Molecular Formula | C15H23N3O4S |
Molecular Weight | 341.4 |
SMILES | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC |
Synonyms | sulpiride 15676-16-1 Sulpyrid Sulpirid Aiglonyl Dolmatil Dogmatil Guastil Dogmatyl Mirbanil Misulvan Neogama Omperan Splotin Sursumid Abilit Dobren Meresa Coolspan Sernevin Sulpitil Sulpirida Synedil N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide Pyrikappl Sulpiridum Sulpor RD 1403 (+-)-sulpiride N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide DTXSID1042574 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide CHEBI:32168 N05AL01 7MNE9M8287 Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy- o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl- NSC-757850 RD-1403 N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide DTXCID9022574 n-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy- Sulperide vertigo neogama vertigo-neogama Vertigo Meresa Vertigo-Meresa N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoyl-benzamide RefChem:56075 N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide 239-753-7 (+/-)-Sulpiride Miradol (RS)-(+/-)-sulpiride Eglonyl Psicocen Pyrkappl Calmoflorine Alimoral Championyl Darleton Desmenat Eusulpid Fardalan Isnamide Kylistro Lisopiride Mariastel Norestran Ozoderpin Stamonevrol Zemorcon Dresent Eglonil Enimon Equilid Fidelan Normum Nufarol Omiryl Restful Suprium Valirem Sulpiridum [INN-Latin] Sulpirida [INN-Spanish] MFCD00055061 dl-sulpiride Levosulpiridum [INN-Latin] Levosulpirida [INN-Spanish] R.D. 1403 CHEMBL26 rac Sulpiride s4655 Sulpiride-R (+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide SMR000038923 CCRIS 4248 SULPIRIDE,(+) Sulpiride [USAN:INN:BAN:JAN] SR-01000075402 EINECS 239-753-7 BRN 0494008 UNII-7MNE9M8287 CCRIS-4248 (y)-Sulpiride Sulpiride, SLP (plusmn)-sulpiride Dogmatyl (TN) Magnetic resonance imaging sulpiride (?)-Sulpiride Prestwick_431 CAS-15676-16-1 Sulpiride (Standard) PS30 - Sulpiride SULPIRIDE [INN] SULPIRIDE [JAN] SULPIRIDE [MI] SULPIRIDE [USAN] (.+/-.)-Sulpiride Prestwick0_000056 Prestwick1_000056 Prestwick2_000056 Prestwick3_000056 SULPIRIDE,(-) Biomol-NT_000037 Biomol-NT_000162 SULPIRIDE [MART.] SCHEMBL8421 SULPIRIDE [WHO-DD] Lopac0_001050 Oprea1_602476 BSPBio_000211 5-22-08-00105 (Beilstein Handbook Reference) MLS000069434 MLS001306443 DivK1c_000278 SPBio_002132 BPBio1_000233 BPBio1_000463 BPBio1_001255 GTPL5501 orb1309432 Sulpiride (JP18/USAN/INN) SULPIRIDE [EP IMPURITY] SCHEMBL29359128 SULPIRIDE [EP MONOGRAPH] BDBM11638 HMS500N20 HY-B1019R KBio1_000278 NINDS_000278 Sulpiride 1.0 mg/ml in Methanol HMS1568K13 HMS2095K13 HMS2231K07 HMS3263A22 HMS3266P12 HMS3371P16 HMS3372O01 HMS3393A08 HMS3411D18 HMS3651G12 HMS3675D18 HMS3712K13 HMS3885J14 HMS5080O10 HMS5083A10 BCP04500 BCP13871 HY-B1019 MSK10053 STR09321 ( inverted question mark)-Sulpiride Tox21_302205 Tox21_501050 HB1835 STK368596 5-(Aminosufonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide AKOS004912732 CCG-205127 CS-4534 DB00391 FS27973 LP01050 NSC 757850 SDCCGSBI-0051020.P002 ( inverted exclamation markA)-Sulpiride IDI1_000278 NCGC00015966-03 NCGC00015966-04 NCGC00015966-05 NCGC00015966-06 NCGC00015966-07 NCGC00015966-08 NCGC00015966-16 NCGC00024852-02 NCGC00024852-03 NCGC00024852-04 NCGC00024852-05 NCGC00255813-01 NCGC00261735-01 AC-12181 SY235220 DB-046215 EU-0001755 EU-0101050 NS00010476 R. D. 1403 D01226 J10067 S 8010 EN300-2010446 676S161 L000579 Q422418 SR-01000075402-2 SR-01000075402-3 SR-01000075402-6 BRD-A55272860-001-03-9 BRD-A55272860-001-04-7 BRD-A55272860-001-08-8 BRD-A55272860-001-14-6 BRD-A55272860-001-15-3 Z84655412 Sulpiride, British Pharmacopoeia (BP) Reference Standard 1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine Sulpiride, European Pharmacopoeia (EP) Reference Standard N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide (+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide (+/-)-N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide N-(1-ETHYL-2-PYRROLIDINYLMETHYL)-2-METHOXY-5-SULFAMIDOBENZAMIDE (+/-)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide ( inverted question mark)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-benzamide ;N-(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamidobenzamide |
Created At | Jan 13, 2025 2:47 pm |
Updated At | Jan 13, 2025 2:47 pm |